The grant process involves inviting specific scientists to respond to a request for applications (RFA). Once those materials are received they are reviewed by the Medical Advisory Board and the Board of Directors of the Inflammatory Breast Cancer Research Foundation.
Dr. Milan Radovich received grant funding to identify new therapeutic targets for inflammatory breast cancer and triple negative breast cancer. This project builds on his work with Dr. Bryan Schneider on a next-generation sequencing project funded in 2009 by the Inflammatory Breast Cancer Research Foundation and the Milburn Foundation. Dr. Radovich is an Associate Professor at the Indiana University School of Medicine and Vice President for Oncology Genomics at Indiana University Health. He is also co-director of the IU Health Precision Genomics Program, a clinical program dedicated to the integration of cutting-edge genomics for the care of metastatic cancer patients.